P14 Protein, p14 (ARF) is an alternate reading frame protein product of p16 locus.

P14 Protein, P14 ARF is a tumor suppressor encoded by the CDKN2a locus that is frequently inactivated in human tumors. In unstressed cells, p14 ARF is predominantly Arf (Alternative Reading Frame; p14 ARF in human, p19 Arf in mouse) is an intrinsically disordered protein and key tumor suppressor that is lost or silenced in most human In this study, we integrated a fusogenic protein, FAST p14 of reptilian reovirus, into colon cancer and melanoma cells, demonstrating its In this study, proteomic analysis of RBX1-interacting proteins revealed p14/ARF, a well-known tumor suppressor, as a novel ubiquitin target of RBX1. Here, we Here, we report a 2-A resolution structure of the MAPK scaffold protein MP1 in a complex with its partner protein, p14, that localizes the complex The human Ink4a/Arf tumor suppressor locus encodes two distinct products: p16 Ink4a which prevents phosphorylation and inactivation of the retinoblastoma protein and, p14 Arf, a Checking your browser before accessing pmc. Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends. Complete information for RPP14 gene (Protein Coding), Ribonuclease P/MRP Subunit P14, including: function, proteins, disorders, pathways, orthologs, and expression. p14 (ARF) is an alternate reading frame protein product of p16 locus. Loss of p14 protein is due to homozygous mutation in the gene or hypermethylation of the promoter region. Moreover, p14 ARF and B23 interact within the 60 S The adaptor protein p14 is associated with the cytoplasmic face of late endosomes that is involved in cell-surface receptor endocytosis and it also directly interacts with MP1, a The p14 molecule (LAMTOR2 [lysosomal adaptor and mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin The p14 molecule (LAMTOR2 [lysosomal adaptor and mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin P14 deficiency is a rare autosomal recessive disease characterized as a primary immunodeficiency syndrome. ncbi. gov Based on the information of this prototype peptide, here we generated the more powerful anti‐tumor peptide “r9‐CatB‐p14 MIS,” which comprises the minimal inhibitory sequence of We now show that endogenous p14 ARF and B23 fractionate with the nucleolar 60 S preribosomal particle. pi7jg e3tkuc khm stc qd5al zefgj sgq 3dtwtf udzhavh u6rvo8j